AVTR - CIK 0001722482
Avantor, Inc. trades as AVTR and has a market capitalization of $6.59 B, making it the #1191 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $6.55B, down 3.4% from the prior year and net income of -$530.20M. This page tracks Avantor, Inc. through 763 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 8 fiscal years Avantor, Inc.'s revenue grew from $1.25B to $6.55B, a compound annual growth rate of 23.0%. Net profit margin expanded from -9.0% to -8.1% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-12 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
In this role, Mr. Porreca is responsible for leading quality assurance, quality systems and regulatory affairs globally across all Avantor's businesses.
Net income of $43 million; Adjusted EBITDA of $219 million
In this role, Mr. Brellier will be responsible for growing the BMP business and improving operational performance. He will also lead the Revival Management Office, driving transformation initiatives across the enterprise.
_Portfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems for R&D through high-volume manufacturing_
The largest companies sharing Avantor, Inc.'s SEC industry classification (laboratory analytical instruments).
Avantor, Inc. (AVTR) has a market capitalization of $6.59 B as of 2026-06-10, ranking #1191 among US-listed companies.
Avantor, Inc. reported revenue of $6.55B for fiscal year 2025, a decrease of 3.4% year over year.
In its latest fiscal year Avantor, Inc. reported a net loss of $530.20M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
_St. Louis site strengthens integrated support for biopharma manufacturing_